Mercer Global Advisors Inc Pyxis Oncology, Inc. Transaction History
Mercer Global Advisors Inc
- $48.3 Billion
- Q2 2025
A detailed history of Mercer Global Advisors Inc transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 10,004 shares of PYXS stock, worth $39,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,004Holding current value
$39,215% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PYXS
# of Institutions
71Shares Held
22.5MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$14.2 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$13.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$10.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$9.8 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$8.43 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $138M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...